Hot Topics in Pain Management [August 2016]
23
Further, it would be helpful to become
familiarized with the AGREE II
instrument domains to know what
information should be reported and
how it ought to be reported in the
CPGs. Here, we also give some pointers
to reduce the variability among the
CPGs:
1. The study should describe the
specific health question it aims to
address, such as prevention,
screening, diagnosis, or treatment,
and target population, including sex,
age clinical condition, severity stage
of the disease, comorbidities, and
others.
2. The guideline development group
should include individuals from all
relevant professional groups, not
only or mainly health care providers.
Competing interests of guideline
development group members should
be fully recorded and addressed.
3. In the guideline development
process, appropriate methodologies
and rigorous strategies are
important for successful
implementation of the resulting
recommendations, such as the
systematic methods and criteria for
selecting the evidence, methods for
formulating the recommendations,
health benefits, side effects
considered in formulating the
recommendations, links between